Skip to product information
1 of 5

Regenwell PH

NAD+ Exosome Skin Booster | Cellular Renewal Microneedling Solution

NAD+ Exosome Skin Booster | Cellular Renewal Microneedling Solution

Regular price ₱2,725.00
Regular price Sale price ₱2,725.00
Sale Available on request
Pack
📦 Pre-Order Item
This kit is available via pre-order and typically ships within 2 weeks after payment confirmation.

Includes FREE bacteriostatic water.

Quantity
Tick the box to enable Add to cart

NAD+ Exosome Skin Booster is a renewal-focused microneedle-infusion solution that pairs NAD+ with exosomes, glyceryl glucoside and hydrolyzed sodium hyaluronate. It is made for skin that looks dull, dry and less resilient with age, and leaves it looking fresher, more hydrated and more settled.

Best for: dullness and fatigue, dryness, fine lines, sensitivity and loss of resilience.

Key ingredients

  • NAD+ supports a fresher, more energized-looking complexion
  • Exosomes support a smoother, more even-looking surface
  • Glyceryl glucoside a long-lasting hydrator that helps skin look plumper
  • Portulaca oleracea extract and allantoin soothe and comfort sensitive skin
  • Hydrolyzed sodium hyaluronate small-molecule hydration

How to use

Made for microneedle infusion at 0.5 mm or shallower with a device such as the Dr Pen. On clean, dry skin, apply the solution and work it in with the device, then follow with a calming moisturizer and sunscreen the next morning. Use once every 1 to 2 weeks. Each 5 ml vial is single-use; discard any leftover. Patch test first, avoid the eye area, and skip exfoliants and retinoids for 2 to 3 days after use.

What's in the box

Single Vial: 1 x 5 ml. Simple Pack: 10 x 5 ml vials.

For external cosmetic use with shallow microneedling only. Not for injection. Not suitable for broken, sunburned or actively irritated skin. Discontinue if irritation persists.

View full details

Who can purchase?

Products are intended for qualified researchers, laboratories, and educational institutions. Regenwell PH reserves the right to refuse orders that do not meet research-use criteria.